NCT06414473View on ClinicalTrials.gov

CBD for Knee Osteoarthritis

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 14, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Cannabidiol (CBD) Extract

Administered thrice daily (with food) using a sublingual route of administration

DRUG

Placebo

Administered thrice daily (with food) using a sublingual route of administration

Trial Locations (1)

32601

RECRUITING

Sports Medicine Research Laboratory, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER